237 related articles for article (PubMed ID: 9701674)
1. Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study.
Snaedal J; Kristinsson J; Gunnarsdóttir S; Olafsdóttir ; Baldvinsson M; Jóhannesson T
Dement Geriatr Cogn Disord; 1998; 9(5):239-42. PubMed ID: 9701674
[TBL] [Abstract][Full Text] [Related]
2. Copper, ceruloplasmin and superoxide dismutase (SOD) in amyotrophic lateral sclerosis.
Tórsdóttir G; Kristinsson J; Gudmundsson G; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 2000 Sep; 87(3):126-30. PubMed ID: 11068853
[TBL] [Abstract][Full Text] [Related]
3. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
Tórsdóttir G; Kristinsson J; Sveinbjörnsdóttir S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 1999 Nov; 85(5):239-43. PubMed ID: 10608487
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
Park JH; Lee DW; Park KS
Asia Pac Psychiatry; 2014 Mar; 6(1):38-45. PubMed ID: 23857910
[TBL] [Abstract][Full Text] [Related]
5. Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
Iskra M; Majewski W
Biol Trace Elem Res; 2000 Jan; 73(1):55-65. PubMed ID: 10949969
[TBL] [Abstract][Full Text] [Related]
6. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
Tórsdóttir G; Kristinsson J; Hreidarsson S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 2001 Dec; 89(6):320-5. PubMed ID: 11903959
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer's disease and is decreased by D-penicillamine.
Rossi L; Squitti R; Pasqualetti P; Marchese E; Cassetta E; Forastiere E; Rotilio G; Rossini PM; Finazzi-Agró A
Neurosci Lett; 2002 Aug; 329(2):137-40. PubMed ID: 12165396
[TBL] [Abstract][Full Text] [Related]
8. Serum copper, zinc, ceruloplasmin and superoxide dismutase in Thai overweight and obese.
Tungtrongchitr R; Pongpaew P; Phonrat B; Tungtrongchitr A; Viroonudomphol D; Vudhivai N; Schelp FP
J Med Assoc Thai; 2003 Jun; 86(6):543-51. PubMed ID: 12924803
[TBL] [Abstract][Full Text] [Related]
9. Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease.
Squitti R; Quattrocchi CC; Salustri C; Rossini PM
Prion; 2008; 2(1):23-7. PubMed ID: 19164917
[TBL] [Abstract][Full Text] [Related]
10. Mineral status and superoxide dismutase enzyme activity in Alzheimer's disease.
Rodrigues GP; Cozzolino SMF; Marreiro DDN; Caldas DRC; da Silva KG; de Sousa Almondes KG; Neto JMM; Pimentel JAC; de Carvalho CMRG; Nogueira NDN
J Trace Elem Med Biol; 2017 Dec; 44():83-87. PubMed ID: 28965606
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease.
Squitti R; Simonelli I; Ventriglia M; Siotto M; Pasqualetti P; Rembach A; Doecke J; Bush AI
J Alzheimers Dis; 2014; 38(4):809-22. PubMed ID: 24072069
[TBL] [Abstract][Full Text] [Related]
12. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
Siotto M; Simonelli I; Pasqualetti P; Mariani S; Caprara D; Bucossi S; Ventriglia M; Molinario R; Antenucci M; Rongioletti M; Rossini PM; Squitti R
J Alzheimers Dis; 2016; 50(4):1181-9. PubMed ID: 26836154
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
Rembach A; Doecke JD; Roberts BR; Watt AD; Faux NG; Volitakis I; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Wilson W; Ellis KA; Martins RN; Rowe CC; Villemagne VL; Ames D; Masters CL; AIBL research group ; Bush AI
J Alzheimers Dis; 2013; 34(1):171-82. PubMed ID: 23168449
[TBL] [Abstract][Full Text] [Related]
14. Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors.
DiSilvestro RA; Goodman J; Dy E; Lavalle G
Breast Cancer Res Treat; 2005 Feb; 89(3):251-5. PubMed ID: 15754123
[TBL] [Abstract][Full Text] [Related]
15. Activities of copper,zinc-superoxide dismutase in erythrocytes and ceruloplasmin in serum in chronic ischemia of lower limbs.
Iskra M; Majewski W
Int J Clin Lab Res; 1999; 29(2):64-7. PubMed ID: 10436263
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).
Sparks DL; Petanceska S; Sabbagh M; Connor D; Soares H; Adler C; Lopez J; Ziolkowski C; Lochhead J; Browne P
Curr Alzheimer Res; 2005 Dec; 2(5):527-39. PubMed ID: 16375656
[TBL] [Abstract][Full Text] [Related]
17. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease.
Vural H; Demirin H; Kara Y; Eren I; Delibas N
J Trace Elem Med Biol; 2010 Jul; 24(3):169-73. PubMed ID: 20569929
[TBL] [Abstract][Full Text] [Related]
18. Copper and ceruloplasmin abnormalities in Alzheimer's disease.
Brewer GJ; Kanzer SH; Zimmerman EA; Celmins DF; Heckman SM; Dick R
Am J Alzheimers Dis Other Demen; 2010 Sep; 25(6):490-7. PubMed ID: 20631161
[TBL] [Abstract][Full Text] [Related]
19. Relevance of non-ceruloplasmin copper to oxidative stress in patients with hepatocellular carcinoma.
Geetha A; Saranya P; Annie Jeyachristy S; Surendran R; Sundaram A
Biol Trace Elem Res; 2009 Sep; 130(3):229-40. PubMed ID: 19229483
[TBL] [Abstract][Full Text] [Related]
20. Changes in erythrocyte superoxide dismutase in a patient with copper deficiency.
Okahata S; Nishi Y; Hatano S; Kobayashi Y; Usui T
Eur J Pediatr; 1980 Aug; 134(2):121-4. PubMed ID: 7439197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
